Spero Therapeutics (SPRO) EBT Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 48,476.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 441.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -408.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,297.00 |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | 315,651.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 315,651.00 |
| Dec 31, 2025 | -59,630.00 |
| Sep 30, 2025 | 43,595.00 |
| Jun 30, 2025 | 129,100.00 |
| Mar 31, 2025 | 122,043.00 |
| Dec 31, 2024 | 9,708.00 |
| Sep 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | 57,393.00 |
| Mar 31, 2024 | 12,789.00 |
| Sep 30, 2023 | 4.95 Mn |
| Jun 30, 2023 | 62,641.00 |
| Mar 31, 2023 | -462,029.00 |
| Dec 31, 2022 | 383,670.00 |
| Sep 30, 2022 | -19,296.00 |
| Jun 30, 2022 | 1.85 Mn |
| Mar 31, 2022 | -138,580.00 |
| Dec 31, 2021 | 45,135.00 |
| Sep 30, 2021 | -157,852.00 |
| Jun 30, 2021 | 127,378.00 |
| Sep 30, 2020 | -4.83 Mn |
| Jun 30, 2020 | 299,659.00 |
| Mar 31, 2020 | 410,802.00 |
| Dec 31, 2019 | -1.72 Mn |
| Sep 30, 2019 | 753,532.00 |